Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem)
- DOI
- 10.3390/ph19101640
- Published
- 2026-10-18
- Container
- Pharmaceuticals
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/ph19101640,
title = {Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem)},
author = {Davor Galusic and Neno Zivkovic and Sandra Basic-Kinda and Barbara Dreta and Marija Ivic and Dino Dujmovic and Martina Moric-Peric and Hrvoje Holik and Neven Franjic and Jasminka Sincic-Petricevic and Ida Hude-Dragicevic and Igor Aurer},
year = {2026},
journal = {Pharmaceuticals},
doi = {10.3390/ph19101640},
url = {https://doi.org/10.3390/ph19101640}
}RIS
TY - JOUR TI - Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem) AU - Davor Galusic AU - Neno Zivkovic AU - Sandra Basic-Kinda AU - Barbara Dreta AU - Marija Ivic AU - Dino Dujmovic AU - Martina Moric-Peric AU - Hrvoje Holik AU - Neven Franjic AU - Jasminka Sincic-Petricevic AU - Ida Hude-Dragicevic AU - Igor Aurer PY - 2026 JO - Pharmaceuticals DO - 10.3390/ph19101640 UR - https://doi.org/10.3390/ph19101640 ER -
APA
Galusic, D., Zivkovic, N., Basic-Kinda, S., Dreta, B., Ivic, M., Dujmovic, D., Moric-Peric, M., Holik, H., Franjic, N., Sincic-Petricevic, J., Hude-Dragicevic, I., & Aurer, I. (2026). Obinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem). Pharmaceuticals. https://doi.org/10.3390/ph19101640
Source records
- crossref · retrieved 2026-11-05T02:06:36.053Z